Shakespeare Wealth Management’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,451
Closed -$217K 93
2024
Q2
$217K Buy
6,451
+13
+0.2% +$449 0.06% 83
2024
Q1
$233K Hold
6,438
0.07% 76
2023
Q4
$210K Hold
6,438
0.07% 82
2023
Q3
$209K Buy
+6,438
New +$206K 0.07% 75
2022
Q1
Sell
-6,438
Closed -$224K 79
2021
Q4
$224K Hold
6,438
0.08% 68
2021
Q3
$215K Hold
6,438
0.08% 70
2021
Q2
$212K Hold
6,438
0.08% 70
2021
Q1
$230K Hold
6,438
0.09% 66
2020
Q4
$218K Buy
+6,438
New +$199K 0.09% 67

Other funds holding GNTX

Shakespeare Wealth Management's GNTX Position: Q3 2024 in Review

Shakespeare Wealth Management sold out of Gentex (GNTX) in Q3 2024, closing a stake of 6,451 shares — an estimated $217K sold.

Shakespeare Wealth Management first reported a position in GNTX in Q4 2020 and held it in 9 quarters. The position peaked at $233K in Q1 2024. 525 funds tracked by Wall St. Rank hold GNTX as of Q3 2024.

  • Shakespeare Wealth Management reported no remaining Gentex position as of Q3 2024 after selling out during the quarter.
  • Shakespeare Wealth Management sold 6,451 Gentex shares in Q3 2024, an estimated $217K.
  • Shakespeare Wealth Management first reported a position in Gentex in Q4 2020 and held it in 9 quarters.
  • Shakespeare Wealth Management's Gentex position peaked at $233K in Q1 2024.
  • 525 funds tracked by Wall St. Rank held Gentex as of Q3 2024.

Based on Shakespeare Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.